Journal of Food, Nutrition and Population Health Open Access

  • ISSN: 2577-0586
  • Journal h-index: 9
  • Journal CiteScore: 1.41
  • Journal Impact Factor: 1.21
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days
Reach us +32 25889658

Research Article - (2018) Volume 2, Issue 1

Diet and Autoimmunity: What is the connection?

Alka Bhatia* and Manjot Sudha

Department of Experimental Medicine and Biotechnology, Postgraduate Institute of Medical Education and Research, Chandigarh, India

*Corresponding Author:

Alka Bhatia
Department of Experimental Medicine and Biotechnology
Research Block B, PGIMER
Chandigarh, India
Tel: 0172-2755271
E-mail: alkabhatia@ymail.com

Received Date: April 06, 2018; Accepted Date: April 19, 2018; Published Date: April 21, 2018

Citation: Bhatia A, Sudha M (2018) Diet and Autoimmunity: What is the Connection?. J Food Nutr Popul Health Vol.2 No.1:7

DOI: 10.21767/2577-0586.10037

Visit for more related articles at Journal of Food, Nutrition and Population Health

Abstract

Autoimmune disorders are characterized by complex multi-factorial etiology. The influence of environmental factors on their etiology is being investigated. Dietary factors that may have possible effect on development of autoimmunity are also being scrutinized. Modern diets are rich in foods which are processed at high temperatures and under conditions of dry heat. These processes are believed to result in formation of toxins with deleterious health effects. Advanced glycation end products are heterogeneous toxins formed in foods subjected to high temperatures while cooking or processing. Although they add to taste and appearance of food their excess has been linked to variety of diseases including autoimmunity. It is important to completely understand their effect on different autoimmune disorders as they are modifiable and can thus help in treatment or prevention of above disorders.

Keywords

Advanced glycation end products; Diet; Autoimmunity; RAGE

Autoimmune diseases are multi-factorial in nature. Role of genetic factors in autoimmunity is well-established, however, environmental and lifestyle factors which may predispose to autoimmunity have not been properly characterized. In view of increasing incidence of autoimmunity it becomes relevant to investigate the effect of environment including dietary factors in etiology of autoimmune disorders. In this context dietary factors have generated interest as potential triggers for autoimmunity [1]. Modern diets include a large number of foodstuffs which are cooked at high temperatures to give them added flavour and texture. However, this leads to enhanced formation of advanced glycation end products (AGEs) the excess of which has been associated with different lifestyle and age related diseases [2].

AGEs are a group of heterogeneous compounds which are formed as a result of glycation reaction. Glycation is basically non-enzymatic attachment of glucose to the amino group of proteins and other biomolecules like DNA and lipids. Maillard reaction occurs that includes the formation of reversible Schiff’s base intermediates, Amadori rearrangement products which ultimately form AGEs by further chemical modifications. The AGEs can be derived either from outside sources (Exogenous) or formed inside the body as a result of normal metabolism (Endogenous). Exogenous AGEs are usually food derived and are known as dietary AGEs (dAGEs). Total body AGE pool comprises of sum total of exogenous and endogenous AGEs [3]. Nε-(1-Carboxymethyl)-L-lysine, Pentosidine and Methylglyoxal are some of the AGEs which have been assessed more commonly in diet.

AGEs have been linked to autoimmunity in several studies conducted on patients as well as experimental animals. Most of the work on AGEs has been done on type 1 diabetes where their presence has been linked to enhanced propensity to develop microvascular complications [4]. Chen et al. noted that interaction of receptor for AGEs (RAGE) with its ligand led to maturation of T cells to pathogenic phenotype in advanced stages of diabetes [5]. In rheumatoid arthritis, serum levels of pentosidine, a fluorescent AGE, have been correlated with the disease activity [6]. Dong et al. in their study on autoimmune uveitis found elevated serum levels of glyceraldehyde-AGEs in patients and treatment with pyridoxamine, an AGE inhibitor, was found to result in reduction in clinical severity of the disease [7]. The possibility of involvement of AGE-RAGE axis in pathophysiology of myasthenia gravis has also been highlighted in some studies [8]. Bayoumy et al. demonstrated decreased soluble RAGE levels in patients with Systemic lupus eryrthematosus thus suggesting the involvement of RAGE pathway in its pathogenesis [9]. However, RAGE is a multiligand protein and whether or not AGEs are majorly responsible as ligands is not well studied. AGEs have also been implicated in pathogenesis of multiple sclerosis (MS) and methylglyoxal derived AGEs have been isolated from brain as well as plasma of MS patients [10].

One of the possible mechanisms responsible for triggering of AGE induced autoimmunity is believed to be the enhanced immunogenicity of AGE modified proteins. Previous studies have shown that AGE modification of proteins like albumin, IgG, LDL, and factor VIII may contribute to their enhanced immunogenicity and formation of antibodies against them [11,12]. The binding of AGEs to RAGE is believed to exhibit pro-inflammatory effects mediated via NFκB and cytokines like IL-6 may further be responsible for pro-autoimmunity immune modulation [13,14]. AGEs have been shown to activate monocytes, thereby leading to increased expression of adhesion molecules, enhanced cytokine production and T-cell proliferation in patients of diabetes mellitus post organ transplantation [15]. Han et al. in their study on incubation of lymphocytes with BSA-glucose derived AGEs found higher differentiation of naive CD4+ T-cells towards Th1/ Th17 phenotype and elimination of suppressive function of T regulatory cells [16]. Indirect effects of AGEs like alteration of gut microbiota may further serve to divert body’s immune milieu towards autoimmunity [17,18].

Although the potential role of AGEs in different autoimmune conditions has been highlighted in several studies a direct link between AGE intake in diet and autoimmunity has not been well explored. Approximately 10-30% of dAGEs may be absorbed. Plasma AGE levels have been found to increase in response to dAGE intake. Studies show that consumption of an AGE rich diet promotes their accumulation in the tissues. Further, dAGEs akin to the endogenous AGEs have also been shown to act as RAGE ligands thereby contributing to the activation of RAGE signalling pathways [19]. Thus, suggesting a direct connection between dietary uptake of AGEs and propensity to develop autoimmunity is not far-fetched. A reduction in dAGEs has been found to be associated with improvement in insulin sensitivity in both animal and human diabetics [20]. Abate et al. in their study showed overcooking of Pasta led to an increase in ROS production and activation of immune response due to IL-8 release. The above factors are known to be involved in etiopathology of autoimmune diseases [21]. The above observations merit further studies to prove the contribution of dAGEs in different autoimmune disorders. Further, intake of which type of AGEs is more deleterious and in what concentration needs to be sorted out. Despite several studies on dAGEs and aging and lifestyle related disorders no threshold/safety limit for AGE intake in diet has been defined! Also one should make an attempt to find out whether the effect of AGEs on immune system is temporary or long lasting. Whether AGEs predispose to autoimmunity in all individuals or only in those with a suitable genetic background? Addressing above questions will help to provide a factor which can be targeted easily to prevent autoimmunity or check its progress.

The concept of possible etiological role of dAGEs in autoimmunity, though, not new, remains in its infancy due to lack of adequate number of studies. Such studies though limited by heterogenous nature of dAGEs are however feasible. Large scale studies characterizing the dAGEs which influence T and B-cell profiles favouring autoimmunity are warranted. Proving the causal or promotional role of dAGEs in autoimmune diseases may pave the way for using anti -AGE molecules for treatment or prevention of autoimmunity.

References

  1. Manzel A, Muller DN, Hafler DA, Erdman SE, Linker RA, et al. (2014) Role of “Western Diet” in Inflammatory Autoimmune Diseases Curr Allergy Asthma Rep 14: 404.
  2. Uribarri, J, Cai W, Sandu O, Peppa M, Goldberg T, et al. (2005) Diet-derived advanced glycation end products are major contributors to the body’s AGE pool and induce inflammation in healthy subjects. Ann N Y Acad Sci 1043: 461-466.
  3. Prasad C, Davis KE, Imrhan V, Juma S, Vijaygopal P (2017) Advanced Glycation End Products and Risks for Chronic Diseases: Intervening Through Lifestyle Modification. American Journal of lifestyle Medicine.
  4. Ljubic TS, Turk N, Benko B (2001) Detection of autoantibodies against advanced glycation endproducts and AGE-immune complexes in serum of patients with diabetes mellitus. Clinica Chimica Acta 303: 105-115.
  5. Chen Y, Yan SS, Colgan J, Zhang HP, Luban J, et al. (2004) Blockade of late stages of autoimmune diabetes by inhibition of the receptor for advanced glycation end products. J Immunol 173: 1399-1405.
  6. Chen JR, Takahashi M, Suzuki M, Kushida K, Miyamoto S, et al. (1998) Pentosidine in synovial fluid in osteoarthritis and rheumatoid arthritis: relationship with disease activity in rheumatoid arthritis. J Rheumatol 25: 2440-2444.
  7. Dong Z, Iwata D, Kitaichi N, Takeuchi M, Sato M, et al. (2014) Amelioration of experimental autoimmune uveoretinitis by inhibition of glyceraldehyde-derived advanced glycation end-product formation. J Leukoc Biol  96: 1077-1085.
  8. Bouchikh M, Zouaidia F, Benhaddou EHA, Mahassini N, Achir A, et al. (2017) Expression of receptor for advanced glycation end-products (RAGE) in thymus from myasthenia patients. Rev Neurol (Paris) 173: 388-395.
  9. Bayoumy N, El-Shabrawi M, Nada H (2013) A Soluble Receptor for Advanced Glycation End Product Levels in Patients with Systemic Lupus Erythematosus 28: 101-108.
  10. Wetzels S, Wouters K, Schalkwijk CG, Vanmierlo T, Hendriks JJA (2017) Methylglyoxal-Derived Advanced Glycation Endproducts in Multiple Sclerosis. Int J Mol Sci18: 421.
  11. Prowse CV, MacGregor IR (1998) Neoantigens and antibodies to factor VIII. Blood Reviews 12: 99-105.
  12. Newkirk MM, Goldbach-Mansky R, Lee J, Hoxworth J, McCoy A, et al. (2003)  Advanced glycation end-product (AGE)-damaged IgG and IgM autoantibodies to IgG-AGE in patients with early synovitis. Arthritis Res Ther 5: R82-R90.
  13. Camporeale A, Poli V (2012) IL-6, IL-17 and STAT3: a holy trinity in auto-immunity? Front Biosci (Landmark Ed). 17: 2306-2326.
  14. Hwang SY, Kim JY, Kim KW, Park MK, Moon Y, et al. (2004) IL-17 induces production of IL-6 and IL-8 in rheumatoid arthritis synovial fibroblasts via NF-κB- and PI3-kinase/Akt-dependent pathways. Arthritis Res Ther 6: R120-128.
  15. Ohashi K, Takahashi HK, Mori S, Liu K, Wake H, et al. (2010) Advanced glycation end products enhance monocyte activation during human mixed lymphocyte reaction Clinical Immunology 134: 345-353.
  16. Han XQ, Gong ZJ, Xu SQ, Li X, Wang LK, et al. (2014) Advanced glycation end products promote differentiation of CD4(+) T helper cells toward pro-inflammatory response. J Huazhong Univ Sci Technolog Med Sci 34: 10-17.
  17. Yacoub R, Nugent M, Cai W, Nadkarni GN, Chaves LD, et al. (2017) Advanced glycation end products dietary restriction effects on bacterial gut microbiota in peritoneal dialysis patients; a randomized open label controlled trial. PLoS ONE 12: e0184789.
  18. Rosser EC, Mauri C (2016) A clinical update on the significance of the gut microbiota in systemic autoimmunity. Journal of Autoimmunity 74: 85-93.
  19. Zill H, Bek S, Hofmann T, Huber J, Frank O, et al. (2003) RAGE-mediated MAPK activation by food-derived AGE and non-AG  E products. Biochem Biophys Res Commun 300: 311-315.
  20. Ottum MS, Mistry AM (2015) Advanced glycation endproducts: modifiable environmental factors profoundly mediate insulin resistance. J Clin Biochem Nutr 2015; 57: 1-12.
  21. Abate G, Delbarba A, Marziano M, Memo M, Uberti D (2015) Advanced Glycation End Products (AGEs) in Food: Focusing on Mediterranean Pasta. J Nutr Food Sci 2015; 5:6.